Westwood Holdings Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,018
Closed -$301K 491
2023
Q1
$301K Buy
6,018
+392
+7% +$18.5K ﹤0.01% 443
2022
Q4
$260K Sell
5,626
-898
-14% -$38.9K ﹤0.01% 475
2022
Q3
$253K Buy
+6,524
New +$262K ﹤0.01% 429
2022
Q2
Sell
-4,955
Closed -$219K 460
2022
Q1
$219K Sell
4,955
-563
-10% -$24.4K ﹤0.01% 443
2021
Q4
$235K Buy
+5,518
New +$232K ﹤0.01% 426

Other funds holding BSX

Westwood Holdings Group's BSX Position: Q2 2023 in Review

Westwood Holdings Group sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 6,018 shares — an estimated $301K sold.

Westwood Holdings Group first reported a position in BSX in Q4 2021 and held it in 5 quarters. The position peaked at $301K in Q1 2023. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • Westwood Holdings Group reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
  • Westwood Holdings Group sold 6,018 Boston Scientific shares in Q2 2023, an estimated $301K.
  • Westwood Holdings Group first reported a position in Boston Scientific in Q4 2021 and held it in 5 quarters.
  • Westwood Holdings Group's Boston Scientific position peaked at $301K in Q1 2023.
  • 1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Westwood Holdings Group's 13F filing for Q2 2023, filed 11 Aug 2023.